Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Cardiovascular pharmacotherapy 2022-05, Vol.8 (3), p.302-310
Hauptverfasser:	Drexel, Heinz, Pocock, Stuart J, Lewis, Basil S, Saely, Christoph H, Kaski, Juan Carlos, Rosano, Giuseppe M C, Tautermann, Gerda, Huber, Kurt, Dopheide, Joern F, Mader, Arthur, Niessner, Alexander, Savarese, Gianluigi, Schmidt, Thomas A, Semb, Anne Grete, Tamargo, Juan, Wassmann, Sven, Clodi, Martin, Kjeldsen, Keld Per, Agewall, Stefan
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Cardiovascular disease Cardiovascular System Clinical trials Drug therapy Evidence-based medicine Hospitals Humans Medicine Product development Randomized Controlled Trials as Topic Statistical methods Ticagrelor Working groups
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!